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Abstract: The tumor surgical treatment and oncology radiation therapy served as medical oncology that contributes to
prime importance in comprehensive treatment of malignant tumors. In recent years, various complications roused
among the after treatment oncology patients and new treatment measures as increasing cause for concern for patients
may vary. The use of individualized integrated treatment method is able to improve the treatment complications. The
enhancement on the patient’s overall quality of life has important significance in clinical practice.
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Overview
In this modern society, human’s living standards and quality has been greatly improved. However, the aging
phenomenon is constantly increasing with elderly, inevitably leading to a number of diseases, including cancer as one of
the predominant disease. At the same time, the environmental pollution, diet changes and heavy work load leads to
stress that are common in middle-aged humans which eventually weaken body immune system. Surprisingly, tumor
incidence rate is rising every year. For the past 50 years, the incidence of cancer has been on the rise, but the occurrence
of the spectrum of cancer varies. Particularlty, cancer occurrence in large cities and developed coastal areas has
increased substantially, mainly due to lifestyle and diet. Clinical cancer related diseases have become one of the high
risk in people’s health. The treatment of cancer patients was performed mainly through chemotherapy, radiation or
surgery. Although chemotherapy is able to reach a certain therapeutic effect, but its side effects would compromise the
patient’s immunity subsequently leading to multiple complications. Thus, there is a need for research and analysis to
develop effective treatment programs. These treatments can be implemented to achieve the best therapeutic effect.
Medical Oncology
Tumor Definition
Cancer can be defined as in living organisms, genetic, malnutrition, endocrine disorders, stress and other internal factors
and long-term effects of physical, chemical, biological and other external factors, local tissue of normal cells of a
qualitative change in the genetic levels, that lost normal regulation of growth, the gene expression disorder, with
different degrees of differentiation and maturation.
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This describes in lost the ability to divide and cause abnormal proliferation and formation of local mass. The
activities and genetic characteristics of the tumor cells and normal cells are biologically different. Due to changes in the
genetic sequence, mutations in cell proliferation will continue to copy the genetic sequence. Even tumor cells from the
tumorigenic effects of above factors are able to multiply indefinitely, and can be transferred to other sites. In medicine,
cancer refers to malignant tumors of epithelial origin, malignant tumor is the most common type. Correspondingly, it
originated in the malignant mesenchymal tissue collectively known as sarcomas. Usually people will classify all
malignancies generally termed as “cancer”. Inflammatory response manifested as difficult to cure or hyperplasia.
Tumourigenesis is a multi-gene, the results of a multi-step mutation. Different genetic mutations have varying intensity
mutagenesis to form different tumour.
Clinical manifestations of malignant tumours
Malignant tumours generally divided into local manifestations and systemic symptoms. Local manifestations include:
(1) Mass: The formation of lumps tumor cell proliferation presence can be found by soft palpation on the surface or
deep palpation. Malignancies including cancer tumor rapid growth, the surface are non-smooth, easy to promote
to benign stage and benign surface is generally smooth, ease in surface sliding. Some of the organ unable to
examined by direct touch, required chest X-ray or CT scan equipment for the examination.
(2) Pain: Tumor expansive growth or lacerations, infection till peripheral nerve, nerve irritation or compression of dry
appear as localized pain. Commonly occur in the middle and late.
(3) Ulcer: Occurred in the body surface or tumors of the gastrointestinal tract. High growth rate of tumours could lead to
insufficient blood supply and caused tissue necrosis or secondary infections that form ulcers.
(4) Bleeding: Carcinoma vascular invasion or cancerous tissue rupture of small blood vessels.
(5) Obstruction: The rapid growth of cancerous tissue could cause obstruction of cavity organs. As a result, site of
obstruction of different tumour with different symptoms.
(6) Others: Bone fractures can lead to tumor invasion, liver cancer caused by reducing serum albumin caused ascites.
Tumor metastasis occurred with corresponding symptoms, such as regional lymph node enlargement.
Systemic symptoms include: Early malignant tumour has no obvious symptoms. Malignant tumour patients commonly
have non-specific symptoms of weight loss, anorexia, cachexia, excessive sweating (night sweats), anemia and fatigue.
Some parts of the tumor can present the corresponding low or hyperthyroidism, secondary systemic changes such as the
adrenal pheochromocytomas cause hypertension. In addition, some tumors such as lung cancer, due to the generation of
endocrine substances, produce and transfer of systemic symptoms unrelated to consumption, ie paraneoplastic
syndrome[1].
Stages of Tumour
According to tumorigenesis and tumor development categorized in five stages:
1) Precancerous: The cells have undergone some changes, but bi-directional development.
2) Carcinoma in situ (commonly referred to as stage 0): a group of abnormal cells in the body.
3) Invasive carcinoma (T stands for general use): Tumor cells have been made to the depths of the site occurred (e.g.
submucosal) infiltration.
4) Local or regional lymph node metastasis (N stands for general use): Tumor cells from the tissue along the lymphatic
metastasis to the lymph nodes.
5) Distant spread (M stands for general use): refers to the transfer of tumor cells with the blood flow to distant organs.
Status medical oncology
In 1946 American doctors Gilman and Philips published the results of the application of nitrogen mustard treatment of
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lymphoma, marking the beginning of modern oncology treatment in the true sense, the United States which was
established in 1965, followed by the Society of Clinical Oncology (ASCO), 1976, and European establishment
oncology (ESMO), held its first session in 2007. China Great China medical oncology (CCMO) is important in the
history of our oncology development were considered milestones.
Oncology is a rapidly developing field in the application of drugs, endocrine, biological and gene therapies for
cancer patients. The integrated treatment of cancer with drug treatment has equal importance as medical treatment,
surgical treatment and radiotherapy.
Over the past half century, medical oncology treatment has established a number of important concepts of biology
and pharmacology including therapeutic targets, and the sensitivity of tumor cell heterogeneity, drugs administration
methods, dose strength, host factors on treatment effect and intergrated chemotherapy, endocrine therapy, biological
therapy. The progress made in all areas of cancer research achieved such as tumor biology, new anticancer drugs and
new mechanisms, chemoprevention, monoclonal antibodies, molecular biology promoted medical advances in the
treatment[2–5].
Classification of tumor treatment
Up to date,there are 7 effective strategies to treat tumors:
1) Surgery, radiation therapy, laser, cryoablation and ethanol injection to eliminate the cancer cells, anticancer drugs or
injection of certain viruses to kill tumour, which is the use of physical, chemical or biological method for treatment of
neoplastic diseases.
2) Administration of different types of anticancer drugs for metastasis inhibition.
3) Targeted therapy, monoclonal antibody used to block tumor specific receptors displayed at the cell surface, mainly
growth factor receptor.
4) Biological treatment by the body own resistance towards the disease.
5) Change the regulation of tumor gene therapy.
6) Inhibition of cancer cells by blocking tumor angiogenesis.
7) Organ transplantation.
Comprehensive treatment of malignant tumours is based on the type, nature, phase, trend, rational, systematic treatment
of the intergrated application in the several existing treatment methods. The aim is to study substantial increase in the
curing process and improvements in the patient’s quality of life.
Chemical treatment was the fundamental cancer treatment. In other countries, the chemicals used to treat Lymphoma
tumor success begins with nitrogen mustard therapy.
Cyclophosphamide and 5-fluorouracil began to implement in clinical cancer therapy. Anthracycline drugs such as
Doxorubicin (Adriamycin®), platinum agents such as cisplatin and carboplatin was used in cancer treatment in
testicular seminoma, choriocarcinoma, acute lymphoblastic leukemia and non-Hodgkin’s lymphoma to achieve radical
results.
Tumour complications
Complication types
Tumours are frequently occurring clinical disease. Since the scope of application of surgical treatment and therapeutic
opportunity has certain limitations, patients usually choose radiotherapy and chemotherapy. Both radiation and
chemotherapy do not only inhibit the sensitive tumour cells, but also had a negative impact on normal cells. This
occurrence was especially in the cells proliferation stage during chemotherapy administration in the patients that could
result in adverse reactions to systemic or local side effects, shock or even life threatening. This could affect the smooth
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administration of chemotherapy. Therefore, in the event of undergoing chemotherapy of radiotherapy, exposure to body
and the tolerance issues of vital organs such as the bone marrow, liver, kidney, heart function, and gastrointestinal
mucosal should be taken into account. To protect these body parts and organs, the dosage of chemotherapy and radiation
were monitored with restrictions.
There were even more complications in the process of radiation therapy and chemotherapy; such as hair loss,
gastrointestinal reaction, myelosuppression, infection, shock. Infection do occurred; such as oral ulcers, pneumonia,
urinary tract infections, peritonitis, shingles, etc. This is a serious issue that affect the quality of life[7] to the extend
where the patients were unable to care for their own self. At the point where the patient realized their own health
condition, they are psychologically unable to overcome their emotion. This creates high psychological burden,
moreover, to an understanding of long term chemotherapy requirement. This prolong burden of economic and
psychological is not an easy task for an ordinary people, often there will be conflict, fear, pessimism, anxiety,
depression, and other negative emotions. These will affect the therapeutic effect and patient compliance to a large
extend and the determination of ways to make consultation for oncology patients with the patients complications under
critical.
Specific complications for adjuvant therapy
In medical oncology department for chemotherapy treatment, a number of patients suffer complications during the time
of observation and analysis. Patients with complications were given adjuvant therapy. Patient were fully prepared
according to the specific requirements set the appropriate treatment program prior to chemotherapy, and the clinical
response in patients was closely monitoring and measurement. Specific adjuvant therapy was carried out according to
individual patient with specific complications circumstances that includes the content of (psychological care,
medication and dietary guidance), treatment drugs include antidepressants, antianxiety drugs, also includes antidiarrheal
drugs, antiemetics drugs, and blood cell growth drugs. In general, chemotherapy patients may be associated with variety
of negative emotions, hair loss, gastrointestinal disorders, drug extravasation and other infectious complication.
Proactive comprehensive nursing should be implemented to reduce complications, improve patient compliance and
degree of nursing satisfaction. Appropriate treatment measures are as follows:
1) Gastrointestinal tract response is a common complication of chemotherapy, the incidence of up to 60%, severe
nausea and vomiting in chemotherapy patients could create a fear in them. Chemotherapy drugs cause nausea, vomiting
mechanism mainly because these drugs can cause gastrointestinal mucosal injury, stimulate intestinal epithelial
pheochromocytoma release 5-HT to stimulate vagal afferent 5-HT receptors, thus central vomiting system initiated that
could cause nausea, vomiting and other gastrointestinal reactions. If vomiting and other symptoms developed, the
patients may be given dopamine receptor blockers drugs and acid-suppressing drugs, such as palonosetron
hydrochloride[8–9]. Intravenous injection of drugs hastens the effect to reduce gastrointestinal reactions during
chemotherapy. On the other hand, nurse and relatives of patients that converse more about a number of topics to the
patients interest could help in reducing gastrointestinal symptoms in patients by diverting attention and maintain
pleasant mood. In the point of patients feels sick, patients should be encourage to take a deep breath. The patient
vomiting head position should be sideways to avoid aspiration; intake and output, appropriate rehydration in patients
with severe vomiting should be recorded. Careful guidance by nursing staff was given to patients while giving
appropriate anti-nausea drug to patients with severe fluid replacement.
2) Cancer patients use more immunosuppressive agents, cytotoxic drugs, anticancer drugs, and these drugs have severe
inhibition of bone marrow hematopoietic function. This would lead to reduction in number of white blood cells in
patients, weakened prevention function mononuclear phagocytic system, damage the body's normal immune barrier,
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eventually the patients prone to infection. Infection is one of the most common complications in cancer patients during
treatment, and the patient if not treated in limited time; the patient's life constitutes a serious threat. Therefore, specimen
collection is the first step and follows by treatment depending on the circumstances. These basic principles at present is
to use the basic mode of antibiotic therapy, in which broad-spectrum antibiotics such as cephalosporins were used in
conjunction with, antibiotics, it has become the standard mode. During the examination of the patient, observation of
physical condition and the bacteria found in patients should provide with reasonable drug combinations. For example,
positive patients use antibiotics generally from 10 days to 14 days; for patients with negative results, even if there is no
corresponding symptoms also required medication against bacteria, until the concentration of neutrophils more than 0.5
× 109 / L; that indicate as negative, but symptoms occur with fever and neutropenia patients, need to consider the
possibility of other assisted infection. Especially the more difficult to treat fungal infections fluconazole
or broad-spectrum antibiotics, etc., and viral infections can consider the use of ribavirin, acyclovir and other drugs.
According to patients current situation of disinfection and isolation, adequate nutrition and rest to strengthen and
enhance immune system and other treatment ensured with internal ward ventilation, reduce family heuristic. The patient
with severe infection, antibiotic medication required to carry out.
3) There are a number of issues and unstable emotions for post-chemotherapy patients psychologically, the nurses
responsible to communicate with the patient, timely order counseling, further to eliminate the negative emotions in the
time to combat the disease with full confidence.
4) Cancer is a non-functional cell, cancer cells captured more nutrients in the body compared to normal cells that leads
to malnutrition for normal cells resulting in decreased in immune system. In terms of diet, proper nursing staff required
for patients treatment and guidance, guidance in patients light free food, easily digestible and less food stimulation.
Moreover, the nurses should encourage the patient to consume food that rich in vitamins, calorie and high-protein
foods[10]. This will naturally help the patients for the nutrition; enhance their resistance, by recording on the patient's
record defecation, and timely treatment, to avoid the occurrence of constipation.
5) Common hair loss in chemotherapy patients, however, hair will grow again once the treatment of chemotherapy
ended. Patients should be explained with proper examples to eliminate patient fear.
6) Intravenous injection of anti-cancer drugs can cause local swelling and leakage occurs, severe or even
thrombophlebitis at the infusion. Right consideration should be taken to puncture the correct site, Drug leakage of
infusion should be replaced and skin should be seal and cold compress.
Conclusion
Individualized treatment aimed at a more specific treatment takes into account the specific condition of the patient’s
illness, the number of drugs required by patients, and the period of time intervals for targeted control. Patients are
medicated according to the instructions after this analysis to develop a more appropriate drug dosage, time of
administration, etc. to ensure the effectiveness of the treatment, and to reduce complications. Clinical staff handling
cancer-related chemotherapy drugs should fully understand and be trained to administer the drugs. Certain patients with
clinical symptoms after treatment will be observed, and the corresponding record of some patients, psychological state
will be monitored with timely counseling.
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